Pilot Conformance Projects Under Development

QIBA Profile Conformance

{This content will eventually be available on the RSNA.org website.}

QIBA Profiles that are at least at consensus level (link to wiki page on development of a Profile) are available to interested parties (clinical sites, CROs, equipment and/or software vendors) to demonstrate that all relevant actors of an institution or product conform to the respective QIBA Profile. There are two different ways to show QIBA Profile conformance:

• Self – attestation
• Certification service

The basic process flow is shown below:

Before starting conformance testing, please Email QIBA

Self Attestation of Conformance

The following QIBA Profiles have reached the Consensus Stage or the Technically Confirmed Stage, and are thus appropriate for self-attestation conformance testing.

CT: Lung Tumor Volume (Advanced Disease)

• Profile
• CT Tumor Volume Change for Advanced Disease (CTV-AD) 2018-06-22
• Checklist

• CT Conformance Checklist (can also refer to Appendix C in the Profile document - pg 42)
• Assessment Procedures (refer to Section 4 in the Profile document - pg 30)
  • CT Conformance Testing Supplement, 2019-11-11

• Report Template

FDG-PET: Solid Tumor SUV

• Profile
• FDG-PET/CT for Response to Cancer Therapy 2016-11-18
• Checklist
• QIBA FDG-PET/CT Conformance Testing Checklist, 2019-11-11
• Report Template

MR: ADC-DW MR Lesions in Four Organs

• Profile
• Diffusion-Weighted Magnetic Resonance Imaging Profile 2019-02-05
• Checklist
• QIBA DWI-MRI Conformance Checklist, 2019-11-11
  • QIBA DWI Conformance Testing Supplement #1, 2019-11-11
  • QIBA DWI Conformance Testing Supplement #2, 2019-11-11
• Report Template

QIBA or Designee Testing of Conformance

CT Small Lung Nodule Volumetry for Screening

• CT Small Lung Nodule Volume Assessment and Monitoring in Low Dose Screening 2018-11-18
• https://www.rsna.org/en/research/quantitative-imaging-biomarkers-alliance/qiba-conformance-certification-services